BioSpace News Archive

The global orthopedic biomaterials market size accounted for USD 82.38 billion in 2022 and is projected to hit around USD 212.6 billion by 2030, growing at a CAGR of 12.58% from 2022 to 2030.

The American College of Radiology (ACR) is set to launch the Contrast-Enhanced Mammography Imaging Screening Trial (CMIST) in collaboration with the Breast Cancer Research Foundation (BCRF) and GE Healthcare.

The TGH+USF Health Bariatric Center has again earned full accreditation as a Comprehensive Center under the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program, a joint program of the American College of Surgeons and the American Society for Metabolic and Bariatric Surgery.

Steamboat Orthopaedic & Spine Institute has completed its first series of cases in the BalancedBack Total Joint Replacement pivotal clinical trial using the breakthrough 3Spine MOTUS lumbar device, which is an alternative to spine fusion surgery.

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended marketing authorization (MA) for a 3-µg dose of COMIRNATY®.

FineHeart S.A, a preclinical medical device company that has developed the ICOMS FLOWMAKER®, a fully Implantable Cardiac Output Management System designed to address the unmet need of patients suffering from severe heart failure, announced that it had been awarded a €2.5 million grant by the European Commission under the highly selective EIC Accelerator program.

Moderna, Inc. announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use has adopted a positive opinion recommending conditional marketing authorization for mRNA-1273.222 as a booster dose for active immunization to prevent COVID-19 caused by SARS-CoV-2 in individuals 12 years of age and older, who have previously received at least a primary vaccination course against COVID-19.

According to Nova one advisor, the global Magnetic Resonance Imaging market size was valued at USD 7.9 billion in 2022 and is predicted to hit USD 10.17 billion by 2030 with a registered CAGR of 4.9% during the forecast period 2022 to 2030

Venus Concept Inc. announced that it has issued a stock option inducement grant to its President and Chief Business Officer, Hemanth Varghese, upon the effective date of his employment agreement on October 17, 2022.

STAAR Surgical Company today announced that it will release financial results for the third quarter ended September 30, 2022 on Wednesday, November 2, 2022 after the market close.